Silverarc Capital Management’s TELA Bio TELA Stock Holding History

Silverarc Capital Management’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Sell	2,137,201 -122,111	-5%	-$99.9K	0.17%	64
2026 Q1	$1.4M	Sell	2,259,312 -388,200	-15%	-$337K	0.14%	63
2025 Q4	$3.12M	Sell	2,647,512 -135,411	-5%	-$171K	0.43%	51
2025 Q3	$4.15M	Buy	2,782,923 +3,128	+0.1%	+$5.51K	0.56%	47
2025 Q2	$5.39M	Buy	2,779,795 +8,507	+0.3%	+$11.1K	0.99%	28
2025 Q1	$3.38M	Sell	2,771,288 -294,361	-10%	-$724K	0.69%	38
2024 Q4	$9.26M	Buy	3,065,649 +1,940,721	+173%	+$5.46M	2.03%	18
2024 Q3	$2.85M	Buy	1,124,928 +124,928	+12%	+$444K	0.64%	44
2024 Q2	$4.7M	Buy	1,000,000 +223,149	+29%	+$1.18M	1.11%	30
2024 Q1	$4.4M	Sell	776,851 -18,229	-2%	-$120K	1.22%	28
2023 Q4	$5.26M	Buy	795,080 +304,609	+62%	+$1.76M	1.57%	26
2023 Q3	$3.92M	Buy	490,471 +74,031	+18%	+$688K	1.19%	36
2023 Q2	$4.22M	Buy	416,440 +362,344	+670%	+$3.71M	1.3%	26
2023 Q1	$576K	Buy	+54,096	New	+$597K	0.24%	64

Other funds holding TELA

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

WealthTrust Axiom Wayne, Pennsylvania $448M AUM 50.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Silverarc Capital Management's TELA Position: Q2 2026 in Review

Silverarc Capital Management reduced its TELA Bio (TELA) stake by 5.4% in Q2 2026, selling an estimated $99.9K and leaving 2,137,201 shares worth $1.6M. The position accounts for 0.17% of the portfolio, ranked #64.

Silverarc Capital Management first reported a position in TELA in Q1 2023 and has held it in 14 quarters since. The position peaked at $9.26M in Q4 2024. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

Silverarc Capital Management held 2,137,201 shares of TELA Bio worth $1.6M as of Q2 2026.
Silverarc Capital Management sold 122,111 TELA Bio shares in Q2 2026, an estimated $99.9K.
TELA Bio made up 0.17% of Silverarc Capital Management's portfolio in Q2 2026, its #64 holding.
Silverarc Capital Management first reported a position in TELA Bio in Q1 2023 and has held it in 14 quarters since.
Silverarc Capital Management's TELA Bio position peaked at $9.26M in Q4 2024.
45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.